Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 43 (4) , 670-674
- https://doi.org/10.1067/mjd.2000.105165
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 503)
- Ministry of Education, Culture, Sports, Science and Technology (10670801)
This publication has 8 references indexed in Scilit:
- Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1999
- Scleroderma: immunopathogenesis and treatmentImmunology Today, 1998
- Low-dose UVA1 phototherapy for treatment of localized sclerodermaPublished by Elsevier ,1998
- Evidence that Singlet Oxygen-induced Human T Helper Cell Apoptosis Is the Basic Mechanism of Ultraviolet-A Radiation PhototherapyThe Journal of Experimental Medicine, 1997
- High-dose UVA1 radiation therapy for localized sclerodermaJournal of the American Academy of Dermatology, 1997
- Control of Fibrosis in Systemic SclerodermaJournal of Investigative Dermatology, 1993
- High-dose UVA1 therapy in the treatment of patients with atopic dermatitisPublished by Elsevier ,1992
- UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivoArchives of Dermatological Research, 1991